GenVisc 850* Knee Pain Relief

Simplifying Access & Reimbursement for Healthcare Providers

GenVisc850® is a hyaluronic acid viscosupplement used to treat knee pain caused by osteoarthritis in patients who have not achieved adequate relief from conservative therapies. The standard treatment consists of up to five intra-articular injections, allowing flexibility based on individual patient needs.

As a distributor, Grole Industries provides comprehensive support to help practices implement GenVisc850®, including reimbursement guidance, coding resources, and ordering assistance. We work closely with providers to simplify access and support successful integration into clinical practice.

Streamlining Knee Pain Treatment

Reimbursement and Support for Healthcare Providers

    • HCPCS Code: J7329 (Hyaluronan or derivative, TriVisc for intra-articular injection, 1 mg)

    • CPT Codes: 20610 (Without ultrasound), 20611 (With ultrasound)

    • NDC Code: 50653-0006-04 (Used as a device proxy for medical device reimbursement)

  • Our Reimbursement Navigator program offers support with benefit verification, prior authorization, coding guidance, and claims assistance, ensuring a smooth experience for healthcare providers.

  • If a claim for TriVisc* is denied, we help identify the cause and assist in resubmitting claims or appealing denials. Our team can guide providers through the process, ensuring that all necessary documentation is submitted to avoid delays in reimbursement.